Literature DB >> 10888912

HIV-1 rebound after anti-retroviral therapy.

D D Ho, L Zhang.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10888912     DOI: 10.1038/77447

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  17 in total

1.  Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.

Authors:  T W Chun; J S Justement; S Moir; C W Hallahan; L A Ehler; S Liu; M McLaughlin; M Dybul; J M Mican; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

2.  A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection.

Authors:  Matthew S Dahabieh; Marcel Ooms; Viviana Simon; Ivan Sadowski
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

3.  Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.

Authors:  Antoine Chaillon; Sara Gianella; Steven M Lada; Josué Perez-Santiago; Parris Jordan; Caroline Ignacio; Maile Karris; Douglas D Richman; Sanjay R Mehta; Susan J Little; Joel O Wertheim; Davey M Smith
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

4.  Impact of Early Antiretroviral Therapy on Detection of Cell-Associated HIV-1 Nucleic Acid in Blood by the Roche Cobas TaqMan Test.

Authors:  Linda L Jagodzinski; Mark M Manak; Holly R Hack; Ying Liu; Jennifer A Malia; Joanna Freeman; Nittaya Phanuphak; Mark de Souza; Eugène D Kroon; Donn J Colby; Nitiya Chomchey; Michelle A Lally; Nelson L Michael; Jintanat Ananworanich; Sheila A Peel
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

5.  Early Antiretroviral Therapy Prevents Viral Infection of Monocytes and Inflammation in Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Henintsoa Rabezanahary; Julien Clain; Gina Racine; Guadalupe Andreani; Ghita Benmadid-Laktout; Chloé Borde; Fabrizio Mammano; Thibault Mesplèdes; Petronela Ancuta; Ouafa Zghidi-Abouzid; Jérôme Estaquier
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

6.  Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs.

Authors:  Ronald P van Rij; Janny A Visser; Rieneke M E van Praag; Ronald Rientsma; Jan M Prins; Joep M A Lange; Hanneke Schuitemaker
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 7.  Role of interleukin-2 in patients with HIV infection.

Authors:  Sarah L Pett; Anthony D Kelleher; Sean Emery
Journal:  Drugs       Date:  2010-06-18       Impact factor: 9.546

Review 8.  Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.

Authors:  Valentin Le Douce; Georges Herbein; Olivier Rohr; Christian Schwartz
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

Review 9.  Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.

Authors:  Jeanne E Bell; Juan-Carlos Arango; Iain C Anthony
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-05       Impact factor: 4.147

Review 10.  Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection.

Authors:  Jordan Poles; Yelina Alvarez; Catarina E Hioe
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.